Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist- Innovative Versatility: Examples of overcoming adversity from Entrepreneurs
- James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
- Figure out How to Streamline Your Profits in Gold Speculation
- Here's what can happen if you drive under the influence of pot
- 'Crammed into a cell with vermin at New Year'
- Huge Iranian missile fragments, intercepted by air defenses, lay scattered across Israel, West Bank
